Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

相似書籍

• Potential mechanism of primary resistance to icotinib in patients with advanced non–small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi‐center study
  由: Lei, Lei, et al.
  出版: (2020)
• Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib
  由: Zhu, You-Cai, et al.
  出版: (2018)
• Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs
  由: Chun-wei Xu, et al.
  出版: (2020-09-01)
• Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs
  由: Xu, Chun-wei, et al.
  出版: (2020)
• A real-world study in advanced non-small cell lung cancer with de novo brain metastasis
  由: Lei, Lei, et al.
  出版: (2021)